These days, cancer researchers aim to design targeted and specific therapy – those that kill cancer but spare the surrounding tissue. Immunotoxins, which use cancer-targeted antibodies linked to deadly toxins such as ricin, ...
Sep 8, 2014
0
0
About one in eight women in the United States will contract breast cancer in her lifetime. Now new research from Tel Aviv University-affiliated researchers, in collaboration with Johns Hopkins University, has provided another ...
May 29, 2014
0
0
A new study in Cell Reports identifies a gene important to breast development and breast cancer, providing a potential new target for drug therapies to treat aggressive types of breast cancer.
Mar 6, 2014
0
0
(Medical Xpress)—A major discovery involving a cellular competition and space compensation mechanism within tissues is the subject of an article published May 27 in Developmental Cell by a research team at Florida State ...
May 29, 2013
0
0
A new research paper was published in Oncotarget on August 3, 2022, entitled, "Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma."
Aug 11, 2022
0
2
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ProCURE program) have published the bases for new therapies against colorectal cancer in Clinical Cancer Research.
Apr 18, 2019
0
0
